AnorMed Agrees To Be Acquired By Genzyme
Seemingly the last words on the acquisition of AnorMED has been sounded; Genzyme will acquire them.
TheStar.com - AnorMed agrees to takeover by Genzyme
Genzyme offer of $13.50 per share ($580 million) was better than Millennium’s bid of $12.00 per share ($515 million). I do think that Millennium may have been the smarter of the two by walking away from the deal although they are entitled to a $19.5 million breakup fee. Genzyme had to up there original order of only $380 million.
The Boston Globe then reported that Millennium is still on the prowl for someone to acquire.
Millennium renews hunt after losing AnorMed to Genzyme - The Boston Globe
So it seems the merger activity will continue. It will be interesting to see who Millennium has there eye on next.
Other Resources
• Yahoo! News Search Results for genzyme millennium anormed
• genzyme millennium anormed - Google News
• Google Blog Search: genzyme millennium anormed
• genzyme millennium anormed - Ask.com Blog and Feed Search
Technorati Tags: Anormed, Genzyme, Millennium, pharma M&A, pharmaceutical deals
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
